Economic burden of echinococcosis patients in endemic areas of western China: a meta-analysis
10.16250/j.32.1915.2025020
- VernacularTitle:基于meta分析的我国西部流行区 棘球蚴病患者经济负担
- Author:
Zhe YIN
1
;
Guangzhong SHI
1
;
Wusiman RENA
1
;
Tuerxunjiang KAISAIER
1
;
Weiqian MA
1
;
Simayi ADILI
1
;
Jiangshan ZHAO
1
Author Information
1. Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention, Xinjiang Key Laboratory of Vector-Borne Infectious Diseases, Urumqi, Xinjiang 830002, China
- Publication Type:Journal Article
- Keywords:
Echinococcosis;
Economic burden;
Meta-analysis;
Western area;
China
- From:
Chinese Journal of Schistosomiasis Control
2025;37(5):506-516
- CountryChina
- Language:Chinese
-
Abstract:
Objective To systematically evaluate the economic burden of echinococcosis patients in western China using meta-analysis, so as to provide insights into formulation of effective echinococcosis control strategies and optimization of medical resource allocation. Methods Articles pertaining to the economic burden of echinococcosis patients in western China were retrieved in international and Chinese databases, including PubMed, Web of Science, CNKI, Wanfang Data, and VIP Chinese Science and Technology Periodicals Full-Text Database. Studies were screened according to inclusion and exclusion criteria, and the basic characteristics of included articles, characteristics of included studies, and echinococcosis patients’ economic burden were extracted. A meta-analysis was performed using the software R package. The pooled effect size and heterogeneity were examined using a random effects model, and subgroup analyses were conducted. Results A total of 13 articles were enrolled, including 12 Chinese publications and one English publication, and all were retrospective studies. Included studies covered 4 western provinces (autonomous regions) of China, including Ningxia Hui Autonomous Region, Xinjiang Uygur Autonomous Region, Sichuan Province, and Qinghai Province, which involved 11 282 echinococcosis patients, and the study period spanned from 2006 to 2023. Meta-analysis showed that the pooled direct medical costs of echinococcosis patients were 24 730 [95% confidence interval (CI): (13 040, 36 430)] Yuan in endemic areas of western China, appearing a significant heterogeneity (I2 = 79.95%, P < 0.01). Subgroup analyses showed the pooled direct medical costs of 9 090 [95% CI: (-4 970, 23 150)] Yuan for echinococcosis patients in Ningxia Hui Autonomous Region and 18 140 [95% CI: (8 440, 27 840)] Yuan in Xinjiang Uygur Autonomous Region, and pooled direct medical costs of 9 470 [95% CI: (-1 850, 20 790)] Yuan for cystic echinococcosis patients prior to 2007 and 15 270 [95% CI: (560, 24 030)] Yuan after 2007, respectively. There were high heterogeneities in the pooled direct medical costs for echinococcosis patients in terms of date of publication (I2 = 82.05%, P < 0.001), treatment modality (I2 = 83.28%, P < 0.001) and type of echinococcosis (I2 = 72.63%, P < 0.001). In addition, the pooled indirect medical costs and direct non-medical costs were 5 670 Yuan and 4 000 Yuan for echinococcosis patients in western regions of China, respectively. Conclusions Echinococcosis patients suffer from a high economic burden in endemic areas of western China, and there are disparities in the direct medical costs for echinococcosis patients depending on disease type, study areas and study period.
